Mentice AB
MN2
Company Profile
Business description
Mentice AB is engaged in the provision of software and hardware simulation solutions for endovascular therapies. Its solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. It operates through three segments: Mentice VIST, Physical Sim, and Ankyras. Geographically majority of the revenue is generated from the Americas, then followed by EMEA.
Contact
Odinsgatan 10
Gothenburg411 03
SWET: +46 313399400
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
135
Stocks News & Analysis
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,875.70 | 32.60 | 0.37% |
| CAC 40 | 8,151.55 | 65.50 | 0.81% |
| DAX 40 | 24,168.90 | 208.31 | 0.87% |
| Dow JONES (US) | 48,323.40 | 437.43 | 0.91% |
| FTSE 100 | 9,833.03 | 58.71 | 0.60% |
| HKSE | 25,498.13 | 29.35 | 0.12% |
| NASDAQ | 23,097.28 | 403.96 | 1.78% |
| Nikkei 225 | 49,001.50 | 510.78 | -1.03% |
| NZX 50 Index | 13,256.77 | 39.14 | -0.29% |
| S&P 500 | 6,807.80 | 86.37 | 1.28% |
| S&P/ASX 200 | 8,588.20 | 31.70 | 0.37% |
| SSE Composite Index | 3,876.37 | 6.09 | 0.16% |